In the space of just over a decade, ReiThera has evolved from a research-driven biotech to one of Europe’s most scientifically rooted CDMOs, leveraging proprietary viral vector platforms to deliver ...
Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue engineering and cell-based therapies for treatment of injuries and diseases.
Southwest Research Institute demonstrated its single-use 3D bioreactor to produce induced Pluripotent Stem Cells (iPSCs), derived from adult skin, blood, and other somatic cells. Useful for ...
Researchers say in future it may be possible to grow personalized organoids from patient’s own tissue, to test potential treatments in advance.
Hosted on MSN
SwRI-developed single-use 3D-printed bioreactor harvests induced Pluripotent Stem Cells
Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue engineering and cell-based therapies for treatment of injuries and diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback